Associated Papers
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.
Williams EA et al.
Neuro-oncology, 2023
37436963 (PubMed )
Supplement: noad121_suppl_supplementary_tables.xlsx › Table_S2
Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Scheipl S et al.
Therapeutic Advances in Medical Oncology, 2021
34367342 (PubMed )
Supplement: sj-xlsx-1-tam-10.1177_17588359211029125.xlsx › FMI_Archer
Deregulation of the Hippo Pathway Promotes Tumor Cell Proliferation Through YAP Activity in Human Sporadic Vestibular Schwannoma.
Zhao F et al.
World Neurosurgery, 2018
Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns.
Chen H et al.
Scientific Reports, 2017
28710469 (PubMed )
Supplement: 41598_2017_5769_MOESM2_ESM.xlsx › Table_S1
Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?
Evans DG et al.
Clinical Genetics, 2007
Select a paper to view details